Nanobionics of Pharmacologically Active Derivatives of Fullerene C60
Source abstract
Abstract
The physical–chemical mechanisms of pharmacologic functioning of amino acid derivatives of fullerene C60 (ADF) have been studied. ADF were shown to penetrate through the lipid bilayer of liposomes without destruction of membrane integrity. ADF are able to carry bivalent metal ions through phospholipid bilayer owing to the formation of complexes. It was shown that stereoisomers of ADF selectively penetrate into phospholipid membranes. In contrast to D-isomers, L-isomers penetrate through the phosphatidylcholine membrane into liposome interior. Stereo-specific effect of ADF enantiomers was also observed in reaction of peroxidation of lipids. Besides that, ADF bring about a substantial increase in the catalytic activity of monoaminoxidases A and B. The directed intraprotein electron transfer was studied by creating a donor–acceptor pair in a water solution in the presence of ADF. To realize the intraprotein electron transfer, the model system was produced on the base of apomyoglobin by incorporating ADF (electron acceptor) into the heme pocket of protein instead of removed heme. It was established that the fullerene C60 and its derivatives did not produce specific anti-C60 antibodies, both IgG and IgE classes, while ADF themselves are efficient adjuvants, i.e. they increased the antibody response to poor antigens. Some ADF were found to inhibit the human immunodeficiency virus and human cytomegalovirus infection.
Source: openaire · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Fullerene Chemistry and Applications · Carbon Nanotubes in Composites · Polymer Nanocomposite Synthesis and Irradiation
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (7)
Show source-provided references
1. Friedman S.H., D.L. De Caamp, R.P. Sijbesma, G. Srdanov, F. Wudl & G.L. Kenyon 1993. Inhibition of the HIV-1 protease by fullerene derivatives: Model studies and experimental verification. J. Am. Chem. Soc. 115, 6506.10.1021/ja00068a005 ↗
2. Gorkin V.Z. & L.V. Tatyanenko 1967. On the inhibition by harmine of oxidative desamination of biogenic monoamines. Life sciences 6, 791–795.10.1016/0024-3205(67)90280-9 ↗
3. Kotelnikova R.A., A.I. Kotelnikov, G.N. Bogdanov, V.S. Romanova, E.F. Kuleshova, Z.N. Parnes & M.E. Vol'pin 1996. Membranotropic properties of water soluble amino acid and peptide derivatives of fullerene C60. FEBS Lett. 389, 111–114.10.1016/0014-5793(96)00537-6 ↗
4. Lowry O.H., N.J. Rosebrough, A.L. Farr & R.J. Randall 1951. Spectrometric method of determination of protein concentration. J. Biol. Chem. 193, 265–275.10.1016/S0021-9258(19)52451-6 ↗
5. Romanova V.S., V.A. Tsyryapkin, Yu.I. Lyakhovetsky, Z.N. Parnes & M.E. Vol'pin 1994. Addition of amino acids and dipeptides to fullerene C60 giving rise to monoadducts. Russian Chem. Bull. 6, 1090–1091.10.1007/BF01558092 ↗
6. Slater T.F., 1972. In: Lagnado J.R. ed. Free Radical Mechanisms in Tissue Injury. Pion Limited, London, pp. 30–41.
7. Tokuyama H., S. Nakamura & E. Nakamura 1993. Photoinduced biochemical activity of fullerene carboxylic acid. J. Am. Chem. Soc. 115, 7918.10.1021/ja00070a064 ↗